PubMed Health⌕ Search

PubMed · 8567343

A multirod collimator for neutron therapy.

Abstract

PURPOSE: To design, construct, and commission a multirod collimator for producing irregularly shaped fields in neutron radiation therapy. To demonstrate the reliability and applicability of this device to routine use with a superconducting cyclotron for neutron therapy. METHODS AND MATERIALS: A multirod collimator has been designed, constructed, and thoroughly tested to investigate its radiological properties; neutron transmission characteristics, beam profiles, and penumbral widths as a function of field size and depth in a phantom, and the spatial resolution of the rod array, have been measured. A wide variety of irregularly shaped fields, used routinely in neutron radiation therapy, have been produced, including fields that incorporate partial transmission blocks. The performance of the collimator has been closely monitored over a period of 20 months to accurately assess reliability. RESULTS: The multirod collimator has been in routine use for 32 months, and during this time a total of 7025 neutron fields has been treated. For the latter 20 months of this period, detailed performance records show that collimator failure has caused 28.4 h of downtime during the patient treatment day. Only 5.25 h of this downtime was experienced in the last 12 months (0.22% of the available treatment time). The results of collimator attenuation and beam profile measurements show that the radiological properties of the collimator are comparable to those of other collimator systems used for neutron radiation therapy. Isodose measurements in a water phantom show that the spatial resolution of the rods is superior to that of the leaves used in neutron multileaf collimators. The ability of the multirod collimator to produce many irregularly shaped fields commonly encountered in neutron radiation therapy has been demonstrated. Shaped fields for prostate, head and neck, soft tissue sarcomas, lung, thyroid, rectum, bladder, colon, breast, pancreas, and gynecological tumors have been produced. For some prostate cases, the device has been used to produce partial transmission blocks. CONCLUSIONS: A novel multirod collimator has been designed, constructed, and successfully applied in the routine treatment of neutron radiation therapy patients.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R L Maughan, G F Blosser, E B Blosser, M Yudelev, J D Forman, H G Blosser, W E Powers. 1996-01-15. A multirod collimator for neutron therapy.. https://doi.org/10.1016/0360-3016(95)02058-6

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Evaluation of a novel approach for peptide sequencing: laser-induced acoustic desorption combined with P(OCH(3))(2)(+) chemical ionization and collision-activated dissociation in a Fourier transform ion cyclotron resonance mass spectrometer.

A novel mass spectrometric method has been developed for obtaining sequence information on small peptides. The peptides are desorbed as intact neutral molecules into a Fourier transform ion cyclotron resonance mass spectrometer (FT-ICR) by means of laser-induced acoustic desorption (LIAD). Reactions of the neutral peptides with the dimethoxyphosphenium ion, P(OCH(3))(2)(+), occur predominantly by addition of the peptide to P(OCH(3))(2)(+) followed by the loss of two methanol molecules, thus yielding product ions with the composition (peptide + P - 2H)(+). Upon sustained off-resonance irradiation for collision-activated dissociation (SORI-CAD), the (peptide + P - 2H)(+) ions undergo successive losses of CO and NHCHR or H(2)O, CO, and NHCHR to yield sequence-related fragment ions in addition to the regular a(n)- and b(n)-type ions. Under the same conditions, SORI-CAD of the analogous protonated peptides predominantly yields the regular a(n)- and b(n)-type ions. The mechanisms of the reactions of peptides with P(OCH(3))(2)(+) and the dissociation of the (peptide + P - 2H)(+) ions were examined by using model peptides and molecular orbital calculations.

Cyclotrons↗

Application of different fragmentation techniques for the analysis of phosphopeptides using a hybrid linear ion trap-FTICR mass spectrometer.

Electron capture dissociation (ECD) and infrared multiphoton dissociation (IRMPD) present complementary techniques for the fragmentation of peptides and proteins in Fourier transform ion cyclotron resonance mass spectrometry (FTICR-MS) in addition to the commonly used collisionally activated dissociation (CAD). Both IRMPD and ECD have been shown to be applicable for an efficient sequencing of peptides and proteins, whereas ECD has proven especially valuable for mapping labile posttranslational modifications (PTMs), such as phosphorylations. In this work, we compare the different fragmentation techniques and MS detection in a linear ion trap and the ICR cell with respect to their abilities to efficiently identify and characterize phosphorylated peptides. For optimizing fragmentation parameters, sets of synthetic peptides with molecular weights ranging from approximately 1 to 4 kDa and different levels of phosphorylation were analyzed. The influence of spectrum averaging for obtaining high-quality spectra was investigated. Our results show that the fragmentation methods CAD and ECD allow for a facilitated analysis of phosphopeptides; however, their general applicability for analyzing phosphopeptides has to be evaluated in each specific case with respect to the given analytical task. The major advantage of complementary peptide cleavages by combining different fragmentation methods is the increased amount of information that is obtained during MS/MS analysis of modified peptides. On the basis of the obtained results, we are planning to design LC time-scale compatible, data-dependent MS/MS methods using the different fragmentation techniques in order to improve the identification and characterization of phosphopeptides.

Cyclotrons↗